National Bank of Canada
BIOA

National Bank of Canada’s BioAge Labs BIOA Stock Holding History

National Bank of Canada’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$418 Sell
24
-21
-47% -$404 ﹤0.01% 2752
2025
Q4 		$594 Hold
45
– – ﹤0.01% 2683
2025
Q3 		$264 Sell
45
-500
-92% -$2.34K ﹤0.01% 2729
2025
Q2 		$2.24K Hold
545
– – ﹤0.01% 2607
2025
Q1 		$2.04K Sell
545
-1,500
-73% -$6.94K ﹤0.01% 2502
2024
Q4 		$11.8K Buy
+2,045
New +$35.3K ﹤0.01% 2290

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

National Bank of Canada's BIOA Position: Q1 2026 in Review

National Bank of Canada reduced its BioAge Labs (BIOA) stake by 47% in Q1 2026, selling an estimated $404 and leaving 24 shares worth $418. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

National Bank of Canada first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.8K in Q4 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • National Bank of Canada held 24 shares of BioAge Labs worth $418 as of Q1 2026.
  • National Bank of Canada sold 21 BioAge Labs shares in Q1 2026, an estimated $404.
  • BioAge Labs made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2752 holding.
  • National Bank of Canada first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • National Bank of Canada's BioAge Labs position peaked at $11.8K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.